We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




2013 Online Pathology Progress Test Now Available

By LabMedica International staff writers
Posted on 17 Dec 2013
The 2013 version of the main exam for progress monitoring and for evaluating and establishing training standards in pathology across Europe is now available.

As of November 25, the 2013 EUROPALS annual pathology test is now available, offered by the European Society of Pathology (ESP) in close collaboration with the European Association of Pathology Chairs & Program Directors (EAPCP). More...
The 2013 test coordinator is Prof. Dr. Fred T. Bosman. It is especially intended for trainees but all ESP member pathologists are free to participate.

The test consists of 100 questions, partly straight, multiple choice questions, partly still-image based and partly virtual-slide based, and extended matching questions. The chosen level is that of a trainee at the end of a residency program. The test comprises of questions with a purely diagnostic orientation, molecular pathology test items, and mechanism of disease-oriented questions.

The test is preferably to be done in one run but can be done in parts if needed. It generally takes approximately 2–2.5 hours in total. A score result will be provided to the test-taker immediately upon completion of the exam. The test is formative—a tool for self-assessment. The results are kept anonymous.

The exam can be taken by logging on to the online (please see Related Links below) with one’s own password; for those without a password, one can be obtained on the website. All existing users are requested to update their Year of Training and Country from “My Account -> Your Details” once logged into PathXL.

Please note prior to taking the test that it is highly recommended to upgrade to the latest versions of Internet Explorer (v9 or v10), Firefox (v24), Google Chrome (v30) or Safari (v5.1.7) for optimal performance and experience. Problems may be experienced using unsupported browsers, such as older versions of Internet Explorer. Tablets or mobile devices are not supported for the test.

Related Links:

European Society of Pathology
Pathxl
EUROPALS Annual Pathology Test



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Slide Scanner System
NanoZoomer S540MD
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.